XBIO Financials 07/16/2014 12:10:06
Xenetic Biosciences, Inc.
Period Ending Dec 31, 2013 Aug 31, 2013 Dec 31, 2012 Aug 31, 2012
Total Revenue 1,000 97 294 113
Cost of Revenue - - 45 -
Gross Profit 1,000 97 249 113
Operating Expenses
Research and Development 3,060 - 1,944 -
Sales, General and Admin. 6,553 124 3,562 210
Non-Recurring Items - - 1,088 -
Other - 39 - 19
Operating Income (8,613) (66) (6,344) (117)
Income From Continuing Operations
Add'l Income/Expense Items 35 (11) 68 -
Earnings Before Interest and Tax (8,579) (76) (6,277) (117)
Interest Expense 1 13 52 13
Earnings Before Tax (8,579) (89) (6,328) (130)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (8,579) (89) (6,328) (130)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (8,579) (89) (6,328) (130)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (8,579) (89) (6,328) (130)